Skip to main content
Advertisement

Main menu

  • Home
  • yabo88官方下载
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • 存档
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • 亚搏软件
  • ag亚博网站
    • ag亚博网站
    • RSS Feeds
  • 亚博8
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • 药理评价
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • ag亚博网站
  • Log in
  • My Cart

Search

  • 亚搏开户网址
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • 药理评价
    • Pharmacology Research & Perspectives
    • ASPET
  • ag亚博网站
  • Log in
  • My Cart
Drug Metabolism & Disposition

亚搏开户网址

  • Home
  • yabo88官方下载
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • 存档
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • 亚搏软件
  • ag亚博网站
    • ag亚博网站
    • RSS Feeds
  • 亚博8
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research Article Article

Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1

R. Scott Obach
Drug Metabolism and Disposition April 2022, 50 (4) 413-421; DOI: https://doi.org/10.1124/dmd.121.000776
R. Scott Obach
Pfizer Inc., Groton, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

oxazolidinone抗菌linezolid一直in clinical use for over 20 years, yet knowledge of the contributions of specific cytochrome (CYP) 450 enzymes to the metabolic clearance of this drug were mostly unknown. In this investigation, it was revealed that three P450 enzymes that had not been previously explored in linezolid metabolism, CYP2J2, CYP4F2, and CYP1B1, catalyzed the 2-hydroxylation and de-ethyleneation of the morpholine moiety of linezolid. The intrinsic clearance for linezolid metabolism in pooled human liver microsomes was low at 0.51 μL/min/mg protein, consistent with its in vivo clearance in humans, and the KMwas high (>200 μM). In recombinant human P450 enzymes, a rank order of intrinsic clearance values for linezolid 2-hydroxylation were CYP2J2 ≫ CYP4F2 > CYP2C8 > CYP1B1 ≈ CYP2D6 ≈ CYP3A4 > CYP1A1 > CYP3A5, with nine other P450 enzymes showing no linezolid metabolism. The effect of selective inhibitors for these eight P450 enzymes on linezolid metabolism in pooled human liver microsomes was evaluated to provide estimates of the relative fractional contributions of these enzymes to linezolid metabolism. These experiments suggest that CYP2J2 and CYP4F2 contribute about 50% each to linezolid hepatic metabolism. It is proposed that the oxidative metabolic clearance of linezolid is primarily catalyzed by these two unusual P450 enzymes and that this explains the lack of observation of meaningful effects of common perpetrators of drug interactions on linezolid pharmacokinetics.

SIGNIFICANCE STATEMENTLinezolid is an important antibacterial drug, but the enzymes involved in its oxidative metabolism were unknown. In this study, evidence is shown that supports an important role for two enzymes not frequently associated with the metabolism of drugs: cytochrome P450 2J2 and cytochrome P450 4F2. These observations offer insight to understand the results of clinical drug-drug interaction studies conducted on linezolid.

Footnotes

    • ReceivedNovember 11, 2021.
    • AcceptedJanuary 5, 2022.
  • This study received no external funding.

  • The author is an employee of and shareholder in Pfizer Inc.

  • dx.doi.org/10.1124/dmd.121.000776.

  • Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

DMD articles become freely available 12 months after publication, and remain freely available for 5 years.

Non-open access articles that fall outside this five year window areavailable only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

Log in using your username and password

Forgotyour user name or password?

Purchase access

You may purchase access to this article. This will require you tocreate an accountif you don't already have one.
Previous
Back to top

In this issue

Drug Metabolism and Disposition: 50 (4)
Drug Metabolism and Disposition
Vol. 50,Issue 4
1 Apr 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research Article Article

Linezolid Metabolism by CYP2J2, CYP4F2, and CYP1B1

R. Scott Obach
Drug Metabolism and Disposition April 1, 2022, 50 (4) 413-421; DOI: https://doi.org/10.1124/dmd.121.000776

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research Article Article

Linezolid Metabolism by CYP2J2, CYP4F2, and CYP1B1

R. Scott Obach
Drug Metabolism and Disposition April 1, 2022, 50 (4) 413-421; DOI: https://doi.org/10.1124/dmd.121.000776
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook像
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • ABBREVIATIONS
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IVIVE Predictability with In Vitro Protein Addition
  • PBPK Predictions of Maternal and Fetoplacental Kinetics
Show moreyabo88官方下载

Similar Articles

Advertisement
  • Home
  • ag亚博网站
Facebook Twitter LinkedIn RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • 存档
  • 亚搏开户网址
  • Feedback
  • ASPET

More Information

  • About DMD
  • 亚搏软件
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • 药理评价
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics